AGC Biologics Announces Plans for New Manufacturing Site in Yokohama Japan
The new four-story 20,000 m² facility will feature mammalian cell culture, messenger RNA and cell therapy services and be operational in 2026SEATTLE,
Silakan masuk menggunakan akun yang telah Anda daftarken untuk mendapatkan informasi yang kami sediakan?